Srinivas Akkaraju bought $10.0M of ALMS
director at ALUMIS INC.. 588,235 shares at an average of $17.00, traded Jan 9, 2026, filed Jan 13, 2026.
Score components
- +15RoleDirector
- +25Trade size$10.0M at market
- +6Relative to holdingsHoldings up 46%
- 0Price contextMid range
- +15Cluster4 insiders buying within 14 days
- +5Repeat buying7 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +21.2%, 3m +3.5%, 6m +23.4%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001253170-26-000004, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 9, 2026 | POpen-market purchase Common Stockindirect: By Samsara Opportunity Fund, L.P. | +588,235 | $17.00 | $10.0M | 1,853,488 | Jan 13, 2026 |
Related signals
Other insiders at ALUMIS INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 46Moderate | ALMSbuy ALUMIS INC. | Srinivas Akkaraju director | $11M 986,721 shares | +22% | |
| 40Moderate | ALMSsell ALUMIS INC. | Srinivas Akkaraju director | $1.0M 96,131 shares | -2% | |
| 38Weak | ALUMIS INC. | Roy C. Hardiman Chief Business & Strategy Ofcr | $71k 2,692 shares | -1% | |
| 51Moderate | ALUMIS INC. | John R. Schroer Chief Financial Officer | $87k 3,282 shares | -12% | |
| 38Weak | ALUMIS INC. | David M Goldstein Chief Scientific Officer | $68k 2,596 shares | -8% | |
| 38Weak | ALUMIS INC. | Jorn Drappa Chief Medical Officer | $65k 2,447 shares | -4% | |
| 38Weak | ALUMIS INC. | Mark Christopher Bradley Chief Development Officer | $68k 2,572 shares | -5% | |
| 41Moderate | ALUMIS INC. | Sanam Pangali Chief Legal Officer | $36k 1,364 shares | -12% | |
| 21Weak | ALMSsell ALUMIS INC. | Sanam Pangali Chief Legal Officer | $140k 5,000 shares | -31% | |
| 63Notable | ALUMIS INC. | James B. Tananbaum director, owner | $7.0M 411,764 shares | +7% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.